Literature DB >> 21354552

Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma.

Zi-Jiang Zhu1, Yang Hu, Yong-Fan Zhao, Xue-Zhong Chen, Long-Qi Chen, Ying-Tai Chen.   

Abstract

BACKGROUND: The aim of this retrospective study is to analyze recurrence and death within 1 year after esophagectomy in patients with esophageal carcinoma.
METHODS: The records of 533 consecutive patients with esophageal squamous cell carcinoma who underwent surgery from January 2002 to January 2005 were reviewed. Patients who died of recurrence within 1 year after operation (group A) were compared with patients who survived more than 5 years without any recurrence (group B). Their clinicopathologic characteristics were evaluated by univariate and multivariate analyses.
RESULTS: The overall 1-year and 5-year survival rates for the entire cohort were 76.1% and 32.3%, respectively, with the follow-up rate of 93.4%. Of the 119 patients who died within 1 year after the esophagectomy, local recurrence or distant metastasis or both were documented in 62 patients (52.1%). The radicality of resection, size of tumor, radicality of resection, grade of differentiation, depth of invasion, status of lymph node metastasis, number of lymph node metastases, and marginal status were shown by univariate analysis to be the significant prognostic factors. By multivariate analysis, they were also the independent prognostic factors, except for the size of tumor and the radicality of resection.
CONCLUSIONS: More than half of early death in esophageal squamous cell carcinoma patients after esophagectomy were still tumor recurrence related, especially hematogeneous spreading. The grade of differentiation, depth of invasion, lymph node metastasis, number of lymph node metastases, and marginal status are valuable prognostic factors in predicting early death.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21354552     DOI: 10.1016/j.athoracsur.2011.01.007

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

1.  Locoregional Tumor Extension and Preoperative Smoking are Significant Risk Factors for Early Recurrence After Esophagectomy for Cancer.

Authors:  Styliani Mantziari; Pierre Allemann; Michael Winiker; Nicolas Demartines; Markus Schäfer
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

2.  Treatment Outcomes and Prognostic Factors After Recurrence of Esophageal Squamous Cell carcinoma.

Authors:  Yoichi Hamai; Jun Hihara; Manabu Emi; Takaoki Furukawa; Yuta Ibuki; Ichiko Yamakita; Tomoaki Kurokawa; Morihito Okada
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

3.  Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.

Authors:  Bo Qi; Jian-Guo Lu; Wen-Jian Yao; Ting-Min Chang; Xiu-Guang Qin; Ying-Hua Ji; Tian-Yun Wang; Shang-Guo Liu; Han-Chen Li; Yu-Zhen Liu; Bao-Sheng Zhao
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  Sevoflurane but not propofol enhances ovarian cancer cell biology through regulating cellular metabolic and signaling mechanisms.

Authors:  Cong Hu; Bincheng Wang; Zhigang Liu; Qiling Chen; Masashi Ishikawa; Han Lin; Qingquan Lian; Jun Li; Jia V Li; Daqing Ma
Journal:  Cell Biol Toxicol       Date:  2022-10-08       Impact factor: 6.819

5.  Genome-wide screening and co-expression network analysis identify recurrence-specific biomarkers of esophageal squamous cell carcinoma.

Authors:  Zong-wu Lin; Jie Gu; Rong-hua Liu; Xiao-ming Liu; Feng-kai Xu; Guang-yin Zhao; Chun-lai Lu; Di Ge
Journal:  Tumour Biol       Date:  2014-08-03

6.  Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinoma.

Authors:  Naoya Yoshida; Yoshifumi Baba; Hironobu Shigaki; Kazuto Harada; Masaaki Iwatsuki; Yasuo Sakamoto; Yuji Miyamoto; Junji Kurashige; Keisuke Kosumi; Ryuma Tokunaga; Masayuki Watanabe; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2016-06-02       Impact factor: 3.402

7.  Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.

Authors:  Sun Tang; Jing Ou; Jun Liu; Yu-Ping Wu; Chang-Qiang Wu; Tian-Wu Chen; Xiao-Ming Zhang; Rui Li; Meng-Jie Tang; Li-Qin Yang; Bang-Guo Tan; Fu-Lin Lu; Jiani Hu
Journal:  Cancer Imaging       Date:  2021-05-26       Impact factor: 3.909

8.  Prognostic value of circulating tumor cells in esophageal cancer.

Authors:  Hai-Tao Xu; Jing Miao; Jian-Wei Liu; Lian-Guo Zhang; Qing-Guang Zhang
Journal:  World J Gastroenterol       Date:  2017-02-21       Impact factor: 5.742

9.  Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.

Authors:  Lucas Goense; Peter S N van Rossum; Mian Xi; Dipen M Maru; Brett W Carter; Gert J Meijer; Linus Ho; Richard van Hillegersberg; Wayne L Hofstetter; Steven H Lin
Journal:  Ann Surg Oncol       Date:  2018-03-22       Impact factor: 5.344

10.  Profiles of patient and tumour characteristics in relation to health-related quality of life after oesophageal cancer surgery.

Authors:  Poorna Anandavadivelan; Anna Wikman; Asif Johar; Pernilla Lagergren
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.